Skip to main content
BioNeutra Global Corporation logo

BioNeutra Global Corporation — Investor Relations & Filings

Ticker · BGA ISIN · CA09073L1067 TSXV Manufacturing
Open in API
Filings indexed 111 across all filing types
Latest filing 2025-06-10 Regulatory Filings
Country CA Canada
Listing TSXV BGA

About BioNeutra Global Corporation

https://www.bioneutra.ca/

BioNeutra Global Corporation engages in the research, development, production, and commercialization of specialized food ingredients targeting the nutraceutical, functional food, and mainstream food and beverage sectors. The company's primary focus is its flagship product, VitaFiber IMO (Isomalto-oligosaccharide). VitaFiber IMO is marketed as a naturally sweet, low-calorie sugar substitute that also serves as a rich source of dietary fiber and prebiotics, supporting digestive health. This ingredient provides manufacturers with a high-quality, health-focused alternative for product formulation.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a press release announcing the termination of the company’s auditor and the future appointment of a successor auditor. It does not contain financial statements or management discussion; it is an announcement of an auditor change rather than a full audit report. This fits best as a general regulatory announcement that does not fall into any other specialized category, making it a Regulatory Filing (RNS).
2025-06-10 English
Notice.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate notice filed under Canadian NI 51-102 regarding the termination of the existing auditor and pending appointment of a new auditor. It is not an audit report itself, nor an annual/interim report, earnings release, or management change announcement. It is a regulatory disclosure of a change of auditor, best matching the fallback category for miscellaneous regulatory filings.
2025-06-06 English
Letter from former auditor.pdf
Regulatory Filings Classification · 1% confidence The document is a short letter from Manning Elliott LLP to Canadian securities commissions acknowledging and commenting on BioNeutra Global Corporation’s Notice of Change of Auditor under NI 51-102. It is not a full audit report or the company’s own filing but rather a regulatory response letter regarding an auditor change. This does not match other specific categories, so it defaults to the general Regulatory Filings category (RNS).
2025-06-06 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a press release announcing the issuance of a Cease Trade Order by the British Columbia Securities Commission due to a delay in filing audited annual financial statements and MD&A. It is not the filing of the report itself, nor an earnings release or management discussion; rather, it is a regulatory compliance update. There is no detailed financial data or report attached, and it does not request shareholder votes or involve share transactions. Therefore it best fits under the fallback category of a general regulatory announcement (RNS).
2025-05-10 English
News release - English.pdf
Share Issue/Capital Change Classification · 1% confidence The document is a press release announcing that the company’s board has approved the grant of stock options (rights to purchase shares) to insiders and employees. This is not a personal insider trade report (DIRS) nor a buyback (POS), nor is it fundraising under CAP. It represents a change in the company’s share capital structure through option grants. This fits the “Share Issue/Capital Change” category (SHA).
2025-03-01 English
Form of proxy - English.pdf
Regulatory Filings
2024-08-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.